Log In
Print this Print this

Pirfenex, pirfenidone (Esbriet, Pirespa) (RG6062, S-7701)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionSmall molecule inhibitor of proinflammatory cytokines and pro-fibrotic cytokines that targets p38 mitogen-activated protein kinase (p38 MAPK; MAPK14)
Molecular Target Tumor necrosis factor (TNF) alpha ; Transforming growth factor (TGF) beta 1 (TGFB1)
Mechanism of ActionMAP kinase (p38) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today